The unique combination of technology marks 25 years of industry innovation and expertise, and signals company’s next phase of ...
AstraZeneca has entered into an exclusive licence agreement with Dizal Pharmaceutical for Zegfrovy (sunvozertinib), a novel ...
Cherry, a full-service creative healthcare agency, has appointed Peter Henshaw as Managing Director. Henshaw will be ...
Exonate has appointed Olav Hellebø as Chief Executive Officer (CEO). Hellebø brings extensive business and scientific ...
Vertex Pharmaceuticals has agreed to acquire Crinetics Pharmaceuticals in a deal worth around $10.0bn. Crinetics is a global ...
Alignment is not proven by whether teams are coordinated, it is proven by whether their combined efforts are sustained ...
Boehringer Ingelheim’s Jascayd (nerandomilast) tablets have been granted marketing authorisation by the Medicines and ...
The UK’s life sciences’ crossroads: competing in a market defined by speed, scale and investment
The UK’s challenge is less about capability and more about how well it aligns with the way global pharma now operates ...
Ipsen is set to acquire Memo Therapeutics in a deal worth more than €700m EUR that is focused on potravitug, a phase 2 ...
Every year, ASCO arrives with a theme. Most quietly disappear into the background by the end of the opening session, ...
Teva Pharmaceutical has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) seeking approval ...
Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results